SCHEMBL24309698

SCHEMBL24309698

Cn1cc(SNc2nc(Oc3ccc(N4CCNCC4)cc3)cc(C3CCCC3)n2)cn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK4 P11802 9/20 0.37
▸ CCND1 P24385 7/20 0.37
▸ CDK2 P24941 3/20 0.37
▸ CDK1 P06493 2/20 0.37
▸ CCNB1 P14635 2/20 0.37
▸ CCNE1 P24864 2/20 0.37
▸ CCND3 P30281 3/20 0.36
▸ HRH4 Q9H3N8 1/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.35
▸ LTA4H P09960 4/20 0.34
▸ FLT3 P36888 3/20 0.34
▸ HTR3E A5X5Y0 1/20 0.33
▸ HTR3B O95264 1/20 0.33
▸ ADRB1 P08588 1/20 0.33
▸ HTR3A P46098 1/20 0.33
▸ HTR3D Q70Z44 1/20 0.33
▸ HTR3C Q8WXA8 1/20 0.33
▸ SIGMAR1 Q99720 1/20 0.33
▸ FGFR1 P11362 2/20 0.33
▸ FGFR2 P21802 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309743 0.85 LTA4H (0.41) CDK2LTA4HFLT3HTR3EHTR3B
SCHEMBL24309788 0.84 GCK (0.36) CDK2CCNA2
SCHEMBL24310587 0.82 FLT3 (0.37) CDK2LTA4HFLT3HTR3EHTR3B
SCHEMBL29566941 0.82 CDK4 (0.38) CDK4CCND1CDK2CDK1CCNB1
SCHEMBL24309695 0.82 CDK4 (0.38) CDK4CCND1CDK2CDK1CCNB1
SCHEMBL24309516 0.82 FLT3 (0.35) CDK4CCND1CDK2CCND3LTA4H
SCHEMBL24309866 0.82 FLT3 (0.36) LTA4HFLT3HTR3EHTR3BADRB1
SCHEMBL24309676 0.82 FLT3 (0.38) CDK4CCND1CDK2LTA4HFLT3
SCHEMBL24309611 0.80 CDK1 (0.34) CDK4CCND1CDK2CDK1CCNB1
SCHEMBL24310582 0.79 CYP1A2 (0.34) HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback